Search Results: "radiation oncology"
All results
22 results for radiation oncology
-
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment…
- Ages
- 18 Years - N/A
- Sexes
- All
-
COMPRO
The purpose of this research study is to learn more about the effects of using proton radiation therapy delivered over a shorter course of treatment (3 weeks)…
- Ages
- 19 Years - N/A
- Sexes
- Female
-
LOGGIC/FIREFLY-2
This is a 2-arm, randomized, open-label, multicenter, global, Phase 3 trial to evaluate the efficacy, safety, and tolerability of tovorafenib monotherapy…
- Ages
- N/A - 25 Years
- Sexes
- All
-
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
This phase III trial compares memantine to placebo in treating patients with primary central nervous system tumors. Memantine may block receptors (parts of…
- Ages
- 4 Years - 17 Years
- Sexes
- All
-
HIFU in Prostate Cancer
This study will investigate the efficacy of focal high intensity focused ultrasound (HIFU) in patients with localized radiorecurrent prostate cancer. This…
- Ages
- 18 Years - N/A
- Sexes
- Male
-
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in…
- Ages
- 3 Years - 29 Years
- Sexes
- All
-
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metast
The primary objective of Part A is to evaluate the safety and tolerability of S-531011 and to determine the maximum tolerated dose (MTD) and/or recommended…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy for Limited mCRC(ERASur)
This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer…
- Ages
- 18 Years - N/A
- Sexes
- All
-
High Risk Prostate CA: Less Intense Tx for Low Risk Scores and More Intense Tx for High Risk Scores
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high…
- Ages
- 18 Years - N/A
- Sexes
- Male
-
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Media
This phase III trial compares the effects of nivolumab with chemo-immunotherapy versus chemo-immunotherapy alone in treating patients with newly diagnosed…
- Ages
- 2 Years - N/A
- Sexes
- All